Hosted on MSN1y
Efficacy and safety of tirzepatide in overweight and obese individuals with type 1 diabetesSatish Garg, MD, from the University of Colorado, Denver, and co-authors, compared a group of adults with type 1 diabetes who were prescribed tirzepatide (off-label) to a control group of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback